Материалы по теме:
Cabaletta Bio开发的体内CAR-T疗法Rese-cel（CD19 CAR-T）在SSc治疗领域取得积极的初步数据，4名系统性硬化症患者停用免疫调节剂后仍维持临床应答，计划2027年提交BLA申请。
。safew官方版本下载是该领域的重要参考
ARIA labels and semantic HTML — screen readers can traverse the full calculation workflow
It was a lot of discussions and more discussions and more discussions.